Open access · OA
via OpenAlex
It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)
Expert Opinion on Biological Therapy · 2013 · ▲ 15 citations
Deregulated nutrient-sensing
Altered intercellular communication
Disabled macroautophagy
Rapamycin / mTOR inhibition
Human
Mouse
Abstract
mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) might have beneficial effects, some of them acting via autophagy(definition), in several cellular, fly and mouse models of degenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and dominant spinocerebellar atrophy (SCA). Other more sophisticated mechanisms have been described such as intervention in cell signaling and cell transcription particularly related to PD. Yet AD, PD, HD and SCA3 are chronic degenerative diseases, and chronic administration of rapamycin at advanced clinical stages may result in deleterious systemic effects due to chronic inhibition of mammalian target of rapamycin (mTOR). Studies are needed to uncover more specific inhibitors of particular mTOR signaling pathways, and to establish realistic guidelines for treatment at early stages of neurodegenerative processes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1517/14712598.2013.799129
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Aso, E., & Ferrer, I. (2013). It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin). <em>Expert Opinion on Biological Therapy</em>. https://doi.org/10.1517/14712598.2013.799129
Vancouver
Aso E, Ferrer I. It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin). Expert Opinion on Biological Therapy. 2013. doi:10.1517/14712598.2013.799129.
BibTeX
@article{ester2013Itmayb,
title = {It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)},
author = {Ester Aso and Isidró Ferrer},
journal = {Expert Opinion on Biological Therapy},
year = {2013},
doi = {10.1517/14712598.2013.799129},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
New cell 2025
Citation only
Targeting neural stem cell senescence for brain aging and neurodegeneration
Aging Pathobiology and Therapeutics 2019
Open access · CC-BY
The rationale for testing drug combinations in aging intervention studies
Research and Reports in Biology 2015
Open access · CC-BY
Recent insights into the pathophysiology of mTOR pathway dysregulation
Science Translational Medicine 2019
Preprint · OA
Rapamycin and Alzheimer’s disease: Time for a clinical trial?
Aging Cell 2023
Open access · CC-BY
Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor
Clinical Interventions in Aging 2023
Open access · CC-BY